Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
Wearable electronic devices such as smart watches, worn by consumers to monitor their health, could interfere with the correct working of cardiac implantable electronic devices (CIEDs), posing serious ...
Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...
In today’s world we have come to rely on our devices, such as smartphones, tablets and laptops, as a key element in all aspects of our lives. Whether it’s letting loved ones know we’re on our way, ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
Please provide your email address to receive an email when new articles are posted on . Pacemakers or implanted cardiac defibrillators that were retrieved postmortem, resterilized and reused in ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results